Analgesics, Opioid: all 2,341 studies that test it
Page 24 of 24. Open to participants first (248), then studies with results posted, then the rest; newest registration first within each.
- Study Comparing Liquid and Tablet Buprenorphine Formulations - 5CompletedNCT00000302Phase 3
- Feasibility Study of Take-Home LAAM Medication - 3CompletedNCT00000300Phase 4
- Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2CompletedNCT00000299Phase 2
- Buprenorphine Combination Tablet Feasibility - 1CompletedNCT00000298Phase 2
- A Laboratory Model for Heroin Abuse Medications - 8CompletedNCT00000273Phase 2
- Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on MethadoneTerminatedNCT00000243Not applicable
- Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22CompletedNCT00000240Phase 2
- Buprenorphine Pharmacology Related to Addiction Treatment - 21CompletedNCT00000239Phase 2
- Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20CompletedNCT00000238Phase 2
- Buprenorphine Detoxification - BBDVI - 19CompletedNCT00000237Phase 2
- Buprenorphine Pharmacology Related to Addiction Treatment - 18CompletedNCT00000236Phase 2
- Alternate Day Buprenorphine Administration, Phase XII - 17CompletedNCT00000235Phase 2
- Alternate Day Buprenorphine Administration, Phase XI - 16CompletedNCT00000234Phase 2
- Alternate Day Buprenorphine Administration, Phase X - 15CompletedNCT00000233Phase 2
- Alternate Day Buprenorphine Administration, Phase IX - 14CompletedNCT00000232Phase 2
- Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13CompletedNCT00000231Phase 2
- Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12CompletedNCT00000230Phase 2
- Buprenorphine Detox With Two Types of Treatment. BBD II - 11CompletedNCT00000229Phase 2
- Buprenorphine Detox With Two Types of Treatment. BBD I - 10CompletedNCT00000228Phase 2
- Alternate-Day Buprenorphine Administration. Phase VIII - 9CompletedNCT00000227Phase 2
- Alternate-Day Buprenorphine Administration. Phase VII - 8CompletedNCT00000226Phase 2
- Alternate-Day Buprenorphine Administration. Phase VI - 7CompletedNCT00000225Phase 2
- Alternate-Day Buprenorphine. Phase V - 6CompletedNCT00000224Phase 1
- Alternate-Day Buprenorphine Administration. Phase IV - 5CompletedNCT00000223Phase 2
- Alternate-Day Buprenorphine Administration. Phase II - 4CompletedNCT00000222Phase 1
- Alternate-Day Buprenorphine Administration. Phase I - 3CompletedNCT00000221Phase 1
- Gradual Vs. Rapid Buprenorphine Detoxification - 2CompletedNCT00000220Phase 1
- Buprenorphine Dose Alteration Study - 1CompletedNCT00000219Phase 1
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1CompletedNCT00000216Phase 3
- IV Cocaine Abuse: A Laboratory Model - 3CompletedNCT00000214Phase 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 2CompletedNCT00000211Phase 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 1CompletedNCT00000210Phase 2
- Buprenorphine Dosing Interval - 5CompletedNCT00000209Phase 2
- Methadone/Buprenorphine Cross-Over Study - 4CompletedNCT00000208Phase 2
- Multicenter Clinical Trial of Buprenorphine - 3CompletedNCT00000207Phase 3
- Clinical Rescue Protocol - 2CompletedNCT00000206Phase 2
- Buprenorphine Maintenance Protocol - 1CompletedNCT00000205Phase 3
- Buprenorphine Maintenance for Opioid Addicts - 3CompletedNCT00000204Phase 2
- Buprenorphine Maintenance for Opioid Addicts - 2CompletedNCT00000203Phase 2
- Buprenorphine Maintenance for Opioid Addicts - 1CompletedNCT00000202Phase 2
- Cocaine Effects in Humans: Physiology and Behavior - 1CompletedNCT00000200Phase 2